Stromal composition and tumor microenvironment (TME), including the number of CD8+ T cells, interferon (IFN-γ) signature, high tumor mutational burden, and programmed death ligand 1 (PD-L1) expression levels, are prognostic factors for treatment response and outcome [8–11]. The gene discussed is CD8A; the disease is neoplasm.